Gastrointestinal bleeding with the new oral anticoagulants--defining the issues and the management strategies

Thromb Haemost. 2013 Aug;110(2):205-12. doi: 10.1160/TH13-02-0150. Epub 2013 May 23.
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects*
  • Atrial Fibrillation / drug therapy
  • Benzimidazoles / adverse effects
  • Dabigatran
  • Endoscopy / adverse effects
  • Gastrointestinal Hemorrhage / chemically induced*
  • Gastrointestinal Hemorrhage / physiopathology
  • Gastrointestinal Hemorrhage / therapy
  • Humans
  • Morpholines / adverse effects
  • Pyrazoles / adverse effects
  • Pyridones / adverse effects
  • Risk Factors
  • Rivaroxaban
  • Stroke / prevention & control
  • Thiophenes / adverse effects
  • Warfarin / adverse effects
  • beta-Alanine / adverse effects
  • beta-Alanine / analogs & derivatives

Substances

  • Anticoagulants
  • Benzimidazoles
  • Morpholines
  • Pyrazoles
  • Pyridones
  • Thiophenes
  • beta-Alanine
  • apixaban
  • Warfarin
  • Rivaroxaban
  • Dabigatran